MEDTECH 2015 – Breaking Barriers to Increase Collaboration and Growth for New York
Wednesday, October 14, 2015
MedTech’s (www.medtech.org) annual conference is the largest gathering of top executives and senior leaders from New York State’s bioscience and medical technology (Bio/Med) industry. MEDTECH 2015 focuses on the need to re-think the way business leaders interact in the healthcare industry – from development through adoption – leveraging the strengths of non-traditional partnerships to produce groundbreaking results. MEDTECH 2015 – “Convergence: Building Momentum for Growth” is kicking off today, October 14, and continuing tomorrow, October 15, at the HARBORCENTER.
“MEDTECH 2015 is our largest conference to date with more than 300 attendees,” said Jessica Crawford, president of MedTech Association. “Our two-day conferenceis educating attendees on how to collaborate for success, while providing a platform to forge lasting relationships with fellow Bio/Med leaders.”
Special guests at the conference include Congressman Chris Collins and Lieutenant Governor Kathy Hochul, as well as keynote speakers Simon Joyeux, partner at Ernst & Young Life Science and Transaction Advisory Services, Christophe Bureau, Ph.D.,vice president of strategic innovation at Stevanato Group S.p.A. and Mike Svinte, vice president, global client engagement, IBM Watson Health.
The conference also marks the release of MedTech’s annual industry report, which provides a foundational assessment of market forces in relation to healthcare reform, while highlighting how member companies are successfully responding to the changing landscape. This year’s report, developed in partnership with our public relations partners at AXON (www.axon-com.com), features articles by Ernst & Young and New York City Economic Development Corporation (NYCEDC), with MedTech member spotlight articles from: Albany Molecular Research Inc. (ARMI), ATW Companies, Cornell University, Excellus BlueCross BlueShield, Gorbel Inc., Greatbatch, Guideline Medical, Sparton Corporation, SUNY Upstate and Welch Allyn. Copies of the report are available for distribution at the conference, as well as for download at www.nybiomedreport.com.
MEDTECH 2015 includes a reverse pitch with representatives from Air Liquide Healthcare, Albany Molecular Research Inc. (AMRI), Johnson & Johnson and PARC, a Xerox company. These sessions provide insight into the Bio/Med leader’s strategic priorities and interest for new partner technologies. Following the reverse pitch sessions, participants have the ability to conduct one-on-one networking meetings to identify mutual interest and potential long term partnerships.
The conference also features an optional tour of the Buffalo Niagara Medical Campus, a workshop, “Tapping into Creativity to Drive Growth,” sponsored by Frost & Sullivan, a Tech Showcase with more than 45 exhibitors, four tracks of programming and multiple networking breakout sessions. Limited on-site registrations are still available for MEDTECH 2015 starting at noon on October 14. http://medtech.org/events/medtech2015/
MEDTECH 2015 – “Convergence: Building Momentum for Growth” is sponsored by Albany Molecular Research Inc. (AMRI), First Niagara Risk Management, Welch Allyn, Baxter, CONMED, Corning and Thermo Fisher.